Cart
sales@molnova.com
S16961
CAS No. 153874-14-7
S16961( S169611 )
Catalog No. M26429 CAS No. 153874-14-7
S16961 is an agonist of nicotinic receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 66 | Get Quote |
|
| 10MG | 88 | Get Quote |
|
| 25MG | 145 | Get Quote |
|
| 50MG | 210 | Get Quote |
|
| 100MG | 310 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameS16961
-
NoteResearch use only, not for human use.
-
Brief DescriptionS16961 is an agonist of nicotinic receptor.
-
DescriptionS16961 is an agonist of nicotinic receptor.
-
In Vitro——
-
In Vivo——
-
SynonymsS169611
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number153874-14-7
-
Formula Weight674.02
-
Molecular FormulaC41H71NO6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)c1cccnc1)OC(=O)CCCCCCCCCCCCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Synthesis of Substituted β‐Functionalised Styrenes by Microwave‐Assisted Olefin
molnova catalog
related products
-
Polymyxin B2
Polymyxin B2 is a polypeptide antibiotic that has antibacterial activity, particularly against gram-negative bacteria.
-
Concizumab
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site.
-
BI-0474
BI-0474 is a potent KRASG12C inhibitor that inhibits GDP-KRAS::SOS1 protein-protein interactions with an IC50 value of 7.0 nM.BI-0474 exhibits significant antiproliferative activity against NCI-H358 cells harboring the G12C mutation, and shows significant anti-tumor activity in a non-small cell lung cancer xenograft model.
